Skip to content
Y70Y70Y70

Drawing based on the label description. No photo yet.

Y70 pill

Pill with imprint Y70 is yellow, round, 8 mm and has been identified as Rabeprazole Sodium 20 mg. It is used for acid reflux (GERD), heartburn and ulcers. It is supplied by Asclemed Usa, Inc.

Rabeprazole Sodium 20 mg

Imprint
Y70
Strength
20 mg
Used for
Acid reflux (GERD), heartburn and ulcers
Color
Yellow
Shape
Round
Size
8 mm
Score
No score line
Form
Tablet, delayed release
Manufacturer
Asclemed Usa, Inc
Drug class
Acid reducer (proton pump inhibitor)
NDC
76420-107, 65862-721, 76420-107-30, 76420-107-60, 76420-107-90, 65862-721-30, 65862-721-90, 71335-1558, 71335-1558-2, 71335-1558-3, 71335-1558-4, 71335-1558-5, 71335-1558-6, 72189-142, 72189-142-90, 72189-142-30

Source: the official drug label on DailyMed (US National Library of Medicine). Last checked .

Report a mistake

Please do not include personal health information. For questions about your medicine, ask a pharmacist.

All Rabeprazole pills and guides

What is Rabeprazole used for?

Rabeprazole is used for acid reflux (GERD), heartburn, ulcers and H. pylori infection.

Medicine type
Acid reducer (proton pump inhibitor)
Official uses from the US prescribing label

Healing of Erosive or Ulcerative GERD in Adults

Rabeprazole sodium delayed-release tablets are indicated for short-term (4 to 8 weeks) treatment in the healing and symptomatic relief of erosive or ulcerative gastroesophageal reflux disease (GERD). For those patients who have not healed after 8 weeks of treatment, an additional 8-week course of rabeprazole sodium delayed-release tablets may be considered.

Maintenance of Healing of Erosive or Ulcerative GERD in Adults

Rabeprazole sodium delayed-release tablets are indicated for maintaining healing and reduction in relapse rates of heartburn symptoms in patients with erosive or ulcerative gastroesophageal reflux disease (GERD Maintenance). Controlled studies do not extend beyond 12 months.

Treatment of Symptomatic GERD in Adults

Rabeprazole sodium delayed-release tablets are indicated for the treatment of daytime and nighttime heartburn and other symptoms associated with GERD in adults for up to 4 weeks.

Healing of Duodenal Ulcers in Adults

Rabeprazole sodium delayed-release tablets are indicated for short-term (up to four weeks) treatment in the healing and symptomatic relief of duodenal ulcers. Most patients heal within four weeks.

Helicobacter pylori Eradication to Reduce the Risk of Duodenal Ulcer Recurrence in Adults

Rabeprazole sodium delayed-release tablets, in combination with amoxicillin and clarithromycin as a three drug regimen, are indicated for the treatment of patients with H. pyloriinfection and duodenal ulcer disease (active or history within the past 5 years) to eradicate H. pylori. Eradication of H. pylorihas been shown to reduce the risk of duodenal ulcer recurrence.

In patients who fail therapy, susceptibility testing should be done. If resistance to clarithromycin is demonstrated or susceptibility testing is not possible, alternative antimicrobial therapy should be instituted.

Treatment of Pathological Hypersecretory Conditions, Including Zollinger-Ellison Syndrome in Adults

Rabeprazole sodium delayed-release tablets are indicated for the long-term treatment of pathological hypersecretory conditions, including Zollinger-Ellison syndrome.

Treatment of Symptomatic GERD in Adolescent Patients 12 Years of Age and Older

Rabeprazole sodium delayed-release tablets are indicated for the treatment of symptomatic GERD in adolescents 12 years of age and above for up to 8 weeks.

From the FDA-approved label on DailyMed (published Sep 29, 2026).

Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.

Is this your pill? Check every detail

  • Your pill shows Y70.
  • It is yellow, round, 8 mm.
  • Its score line and coating match the details on this page.
  • It came from a pharmacy package that names the same drug.

Ingredients

Active: Rabeprazole Sodium

Inactive: Crospovidone (120 .mu.m), Diacetylated Monoglycerides, Ethylcellulose (7 Mpa.s), Ferric Oxide Yellow, Hydroxypropyl Cellulose (110000 Wamw), Hypromellose Phthalate (31% Phthalate, 40 Cst), Low-Substituted Hydroxypropyl Cellulose, Unspecified, Magnesium Stearate, Mannitol, Magnesium Oxide, Magnesium Hydroxide, Sodium Carbonate, Talc, Titanium Dioxide, Ferrosoferric Oxide, Shellac

Also distributed by

Aurobindo Pharma Limited, Bryant Ranch Prepack, Direct Rx

Pills that look similar but are different drugs

Same color and shape, different medicine. This is why the imprint matters.

Other Rabeprazole pills